Back to LRMR
MARSHALL WACE, LLP LRMR Position History
Larimar Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$5M
Q2 2026
Peak value
$5M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $267K |
| Q1 2024 | $757K |
| Q2 2024 | $690K |
| Q3 2024 | $475K |
| Q4 2024 | $15K |
| Q4 2024 | $412K |
| Q1 2026 | $123K |
| Q1 2026 | $4.1M |
| Q2 2026 | $1.1M |
| Q2 2026 | $5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $5M | 1.65M | — | — |
| Q2 2026 | $1.1M | 358.3K | — | — |
| Q1 2026 | $4.1M | 906.1K | — | — |
| Q1 2026 | $123K | 27.4K | — | — |
| Q4 2024 | $412K | 106.5K | — | — |
| Q4 2024 | $15K | 3.8K | — | — |
| Q3 2024 | $475K | 72.5K | — | — |
| Q2 2024 | $690K | 95.2K | — | — |
| Q1 2024 | $757K | 99.8K | — | — |
| Q1 2023 | $267K | 58.9K | — | — |